Terminated PHASE2 INTERVENTIONAL 2-arm NCT04880603

Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site

Sponsor: Acera Surgical, Inc.

Interventions Restrata Graft Standard of Care Skin Graft

Updated 4 times since 2021 Last updated: May 9, 2022 Started: Apr 5, 2021 Primary completion: Apr 25, 2022 Completion: Apr 25, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Investigators no longer interested in pursuing

Other terminated trials from Acera Surgical, Inc.

More terminations from Acera Surgical, Inc.

Other Head and Neck Cancer trials with similar outcome

Browse all Head and Neck Cancer trials

Listed as NCT04880603, this PHASE2 trial focuses on Head and Neck Cancer and remains terminated or withdrawn. Sponsored by Acera Surgical, Inc., it has been updated 4 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jun 2022 — Jul 2024 [monthly]

Terminated PHASE2

Status: Recruiting → Terminated
Jun 2021 — Jun 2022 [monthly]

Recruiting PHASE2

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Acera Surgical, Inc.
Nebraska Methodist Health System

Data source: Nebraska Methodist Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Omaha, United States